Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
HIV-1
Sort By
Newest First
1 / 1
1 / 1
HIV-1
FDA Authorizes Marketing of First Next-Generation Sequencing Test for Detecting HIV-1 Drug Resistance Mutations
U.S. Food & Drug Administration
PR-M11-19-NI-008
Nov 08, 2019
HIV Prevention
FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic
The US Food & Drug Administration
PR-M10-19-NI-008
Oct 07, 2019
Study Results
Janssen Reports Positive Topline Results for ATLAS Phase III Study of a Novel, Long Acting Injectable Two-Drug Regimen for the Treatment of HIV-1
Janssen Pharmaceutical Companies
PR-M09-18-NI-045
Sep 17, 2018
FDA Approval
Merck’s HIV-1 Drugs Delstrigo and Pifeltro Get FDA Approval
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M09-18-NI-003
Sep 06, 2018
Commission Approval
Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-1
Janssen Pharmaceutical Companies
PR-M05-18-NI-088
May 23, 2018
Treatment
New Single-Pill HIV Treatment Approved in Europe
Guy Tiene
Nice Insight
PAO-M05-18-NI-015
May 22, 2018
FDA Approval
U.S. Food and Drug Administration Approves Expanded Indication for Truvada®
Gilead Sciences
PR-M05-18-NI-073
May 18, 2018
